Source: Eur Respir J 2011; 38: 1420-1424
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Musk A.W., Olsen N., Alfonso H., Reid A., Mina R., Franklin P., Sleith J., Hammond N., Threlfall T., Shilkin K.B., de Klerk N.H.. Predicting survival in malignant mesothelioma. Eur Respir J 2011; 38: 1420-1424

Member's Comments

No comment yet.

Related content which might interest you: Predicting survival in mesothelioma Source: Eur Respir J 2012; 40: 1582 Year: 2012 Predicting survival in malignant mesothelioma}, Source: Eur Respir J 2012; 40: 799 Year: 2012 Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002 Clinical characteristics, treatment and survival outcomes in malignant mesothelioma Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 PET predicts survival in malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=290 Year: 2007 Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007 Malignant mesothelioma and chemotherapy: efficacy and influence on survival of patients Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002 Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003 Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Management of malignant mesothelioma Source: ERS Skills Course 2018 - Practical Pleural Skills Year: 2018 Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma Source: Eur Respir J , 49 (3) 1601428; DOI: 10.1183/13993003.01428-2016 Year: 2017 Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019 Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast carcinoma Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008 Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010